Malaysian researchers found that treatment with the anti-parasite drug ivermectin did not prevent patients with COVID-19 from becoming severely ill in a randomized clinical trial published in the JAMA Internal Medicine journal on Friday. The researchers said their findings do not support the use of ivermectin for patients with COVID-19. The study enrolled 490 patients with mild to moderate illness at 20 hospitals and a COVID-19 quarantine center in Malaysia. Everyone received standard care; half the group also received ivermectin. Severe disease developed in 21.6% of the patients given ivermectin and in 17.3% of those who received only standard care,...